Zogenix, Inc.
5959 Horton St 5th floor
Emeryville
California
94608
United States
Website: http://www.zogenix.com/
Email: info@zogenix.com
335 articles about Zogenix, Inc.
-
Zogenix, Inc., Astellas Pharma Inc. Enter Co-promotion Agreement
8/3/2009
-
Zogenix, Inc.'s Sumavel(TM) DosePro(TM) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
7/16/2009
-
Zogenix, Inc. Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM) - Potential Final Approval July 2009
2/18/2009
-
Zogenix, Inc. Closes $18 Million Financing
7/29/2008
-
Zogenix, Inc. Announces Clinical Study Results for sumatriptan DosePro™, a Novel Migraine Treatment
6/30/2008
-
Zogenix, Inc. Completes Management Team with Cynthia Robinson, Ph.D., CDO, & Mark Thompson, VP, Sales & Managed Markets
4/17/2008
-
Zogenix, Inc. Files Registration Statement for Proposed Initial Public Offering
3/24/2008
-
Zogenix, Inc. Announces sumatriptan DosePro NDA Accepted for Filing by FDA
3/20/2008
-
Zogenix, Inc. Licenses European Development and Commercial Rights for Sumatriptan DosePro(TM) to Desitin Pharmaceuticals GmbH
3/18/2008
-
Zogenix, Inc. Raises $18 Million in Preferred Stock Financing
1/9/2008
-
Zogenix, Inc. Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan Corporation PLC
11/28/2007
-
Zogenix, Inc. Appoints David Nassif Executive Vice President and Chief Financial Officer
6/7/2007
-
Zogenix, Inc. Closes $10 Million Deal with GE Healthcare Financial Services
3/19/2007
-
Zogenix, Inc. Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
10/16/2006
-
Zogenix, Inc. Raises $60 Million, Buys Product
8/28/2006